Open for inclusion

First –in human, dose-escalating safety study of tissue factor specific antibody drug conjugate(Humax-TF-ADC) in patients with locally advanced and/or metastatic solid tumors known to express tissue factor

Cancer type: Multiple diagnosis, Solide tumores

Phase: I

Principal Investigator: Yachnin Jeffrey

Country: SE

Keywords: Sweden, Karolinska University Hospital

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02001623?term=FIRST-IN-HUMAN%2C+DOSE-ESCALATING+SAFETY+STUDY+OF+TISSUE+FACTOR+SPECIFIC+ANTIBODY+DRUG+CONJUGATE+%28HUMAX%C2%AE-TF-ADC%29+IN+PATIENTS+WITH+LOCALLY+ADVANCED+AND%2FOR+METASTATIC+SOLID+TUMORS+KNOWN+TO+EXPR